Conduent Introduces GenAI Solution for FDA Compliance
Conduent Incorporated (Nasdaq: CNDT), a global provider of technology-driven business solutions, has launched a new Generative AI-powered platform designed to transform how reportable events are detected in the pharmaceutical and life sciences sectors.
Automation of Reportable Event Detection
The innovative system utilizes Microsoft Azure OpenAI to automate the identification of reportable events across all customer communication channels, enhancing accuracy and compliance.
Impact on Pharma and Life Sciences
- Streamlines compliance processes for companies regulated by the FDA
- Improves detection efficiency and reduces human error
- Supports comprehensive monitoring across multiple customer touchpoints
Contact Information
- Media: Sean Collins, +1-310-497-9205, [email protected]
- Investor Relations: Joshua Overholt, [email protected]
“Our GenAI solution sets a new industry standard by leveraging advanced AI to ensure companies stay compliant with FDA reporting requirements across every interaction,” said Conduent representatives.
Conduent's integration of AI technology marks a significant advancement in regulatory compliance and operational efficiency in the pharmaceutical industry.